UnitedHealth Group (NYSE:UNH) Shares Acquired Rep. Marjorie Taylor Greene

Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on May 19th, the Representative disclosed that they had bought between $15,001 and $50,000 in UnitedHealth Group stock on May 14th.

Representative Marjorie Taylor Greene also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 5/16/2025.
• Purchased $1,001 - $15,000 in shares of Eli Lilly and Company NYSE: LLY on 5/14/2025.
• Purchased $1,001 - $15,000 in shares of Impinj NASDAQ: PI on 5/14/2025.
• Purchased $1,001 - $15,000 in shares of Corning NYSE: GLW on 5/14/2025.
• Purchased $1,001 - $15,000 in shares of Cardinal Health NYSE: CAH on 5/14/2025.
• Purchased $1,001 - $15,000 in shares of Chevron NYSE: CVX on 5/14/2025.
• Purchased $1,001 - $15,000 in shares of Blackstone NYSE: BX on 5/14/2025.
• Purchased $1,001 - $15,000 in shares of ServiceNow NYSE: NOW on 5/14/2025.
• Purchased $1,001 - $15,000 in shares of Hershey NYSE: HSY on 5/14/2025.
• Purchased $1,001 - $15,000 in shares of Tesla NASDAQ: TSLA on 5/14/2025.

UnitedHealth Group Trading Down 0.4%

Shares of NYSE:UNH traded down $1.30 during trading on Friday, reaching $295.37. 16,808,920 shares of the stock were exchanged, compared to its average volume of 6,601,348. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The firm has a market cap of $267.94 billion, a price-to-earnings ratio of 19.06, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The firm's 50-day moving average price is $452.40 and its 200 day moving average price is $504.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the previous year, the company earned $6.91 earnings per share. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.84%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is currently 35.18%.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction on Wednesday, May 14th. The shares were bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the purchase, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director John H. Noseworthy acquired 300 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was bought at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the completion of the acquisition, the director now owns 6,063 shares in the company, valued at $1,892,626.08. This trade represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 109,408 shares of company stock valued at $31,607,768 in the last three months. 0.33% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Robert W. Baird decreased their target price on UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating for the company in a research note on Wednesday, May 14th. Royal Bank of Canada cut their target price on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective for the company. in a research note on Monday, May 19th. HSBC reissued a "reduce" rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday. Finally, Oppenheimer reduced their price target on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $441.87.

Hedge Funds Weigh In On UnitedHealth Group

A number of large investors have recently made changes to their positions in the company. Financial Management Professionals Inc. raised its position in UnitedHealth Group by 0.8% during the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after buying an additional 17 shares during the last quarter. Western Pacific Wealth Management LP raised its position in UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock worth $456,000 after buying an additional 19 shares during the last quarter. MCF Advisors LLC raised its position in UnitedHealth Group by 0.8% during the 4th quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate's stock worth $1,304,000 after buying an additional 20 shares during the last quarter. Axiom Financial Strategies LLC raised its position in UnitedHealth Group by 3.6% during the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock worth $291,000 after buying an additional 20 shares during the last quarter. Finally, Richwood Investment Advisors LLC increased its holdings in shares of UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock valued at $2,654,000 after purchasing an additional 20 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

About Representative Greene

Marjorie Taylor Greene (Republican Party) is a member of the U.S. House, representing Georgia's 14th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027. Greene (Republican Party) is running for re-election to the U.S. House to represent Georgia's 14th Congressional District. She declared candidacy for the 2026 election.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.